CHRISTOPHER BUNKA
CIK 1103780 · Chief Executive Officer · last filed 2026-03-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$341.3K
Companies
2
Total Filings
294
Lifetime Open-Market Net
$103.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LEXX | Director | 555,455 | $0.61 | $341.3K | $0 | 1 | 2026-03-18 |
| Lexaria Bioscience Corp. (LEXXW) Delisted | Chief Executive Officer | 627,955 | $0.00 | $754 | $103.6K | 12 | 2025-07-30 |
Recent Filings · Page 4 of 30
294 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-08-22 | — | Buy (P) | +19,800 | $2.5K | |
| 2016-08-18 | — | Buy (P) | +13,340 | $1.8K | |
| 2016-08-15 | — | Buy (P) | +10,000 | $1.5K | |
| 2016-08-11 | — | Buy (P) | +450,000 | $27.0K | |
| 2016-08-05 | — | Buy (P) | +5,000 | $645 | |
| 2016-07-26 | — | Buy (P) | +24,083 | $2.9K | |
| 2016-07-22 | — | Buy (P) | +7,500 | $932 | |
| 2016-07-19 | — | Buy (P) | +7,000 | $952 | |
| 2016-07-15 | — | Buy (P) | +62,305 | $7.4K | |
| 2016-07-13 | — | Buy (P) | +12,000 | $1.4K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.